- Home
- CYTK vs VNT Comparison
CYTK vs VNT Comparison
Compare CYTK & VNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYTK
- VNT
- Stock Information
- Founded
- CYTK 1997
- VNT 2019
- Country
- CYTK United States
- VNT United States
- Employees
- CYTK N/A
- VNT 8000
- Industry
- CYTK Biotechnology: Pharmaceutical Preparations
- VNT Industrial Machinery/Components
- Sector
- CYTK Health Care
- VNT Industrials
- Exchange
- CYTK Nasdaq
- VNT Nasdaq
- Market Cap
- CYTK 5.6B
- VNT 5.4B
- IPO Year
- CYTK 2004
- VNT N/A
- Fundamental
- Price
- CYTK $34.36
- VNT $38.05
- Analyst Decision
- CYTK Buy
- VNT Buy
- Analyst Count
- CYTK 14
- VNT 7
- Target Price
- CYTK $70.92
- VNT $44.20
- AVG Volume (30 Days)
- CYTK 1.4M
- VNT 874.0K
- Earning Date
- CYTK 08-07-2025
- VNT 07-31-2025
- Dividend Yield
- CYTK N/A
- VNT 0.26%
- EPS Growth
- CYTK N/A
- VNT N/A
- EPS
- CYTK N/A
- VNT 2.46
- Revenue
- CYTK $19,218,000.00
- VNT $2,964,300,000.00
- Revenue This Year
- CYTK $34.81
- VNT $2.28
- Revenue Next Year
- CYTK $643.79
- VNT $5.05
- P/E Ratio
- CYTK N/A
- VNT $15.42
- Revenue Growth
- CYTK 412.21
- VNT N/A
- 52 Week Low
- CYTK $29.31
- VNT $27.22
- 52 Week High
- CYTK $61.38
- VNT $41.61
- Technical
- Relative Strength Index (RSI)
- CYTK 56.37
- VNT 66.07
- Support Level
- CYTK $32.66
- VNT $36.60
- Resistance Level
- CYTK $34.34
- VNT $37.58
- Average True Range (ATR)
- CYTK 1.33
- VNT 0.71
- MACD
- CYTK 0.21
- VNT 0.09
- Stochastic Oscillator
- CYTK 76.45
- VNT 98.95
About CYTK Cytokinetics Incorporated
Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
About VNT Vontier Corporation
Vontier, spun off from Fortive in 2020, is an industrial technology company with a portfolio of transportation and mobility solutions. The company offers a wide array of products and services, including fueling equipment, sensors, point-of-sale and payment systems, telematics, and equipment used by vehicle mechanics and technicians. Vontier generated approximately $3 billion in sales in 2024.